Headache
OnabotulinumtoxinA treatment among diverse racial groups: Post hoc analysis of the phase 4 Chronic migraine OnabotulinuMtoxinA Prolonged Efficacy open-Label (COMPEL) trial.
Andrew M Blumenfeld, Larry Charleston, Deena Kuruvilla, Belinda Savage-Edwards, Richard B Lipton, Ritu Singh, Patricia Jacob, Nicole A Lawrence, Cuiwei Wang, Hope L O'Brien
Published: 202510.1111/head.70007
Abstract
OBJECTIVE: Examine treatment responses to and safety of onabotulinumtoxinA for the preventive treatment of chronic migraine (CM) among diverse racial groups. BACKGROUND: Evidence suggests there are differences in headache treatment patterns, symptom…
Preview only. Read the full abstract at the source